New data being presented at the American College of Gastroenterology (ACG) 2009 Annual Scientific Meeting in San Diego showed that treatment with KAPIDEX(TM) (dexlansoprazole) delayed release capsules over a four-week period resulted in a statistically significant greater percentage of nights without heartburn in subjects with non-erosive gastroesophageal reflux disease (GERD), compared to placebo (p
Recent Posts
- Medarex Highlights Oncology Pipeline At Needham Cancer Therapeutics Conference In New York City
- CME LLC Highlights Full Curriculum And Special Events For Its 20th Annual U.S. Psychiatric And Mental Health Congress
- Canadian Employers Burdened With Mental Health, The Most Costly Disability
- Half Of Children In Welfare System Have History Of Special Health Care Needs
- Use Of Color-Coded Patient Wristbands Creates Unnecessary Risk
- Surprising Airbag Hazards Among Research Findings At Hearing Safety Conference
- Op-Eds Address Presidential Candidates' Health Care Proposals
- Over Half Of Cot Deaths Occur Whilst Co-sleeping
- Lower Occurrence Of Atopic Dermatitis In Children Thanks To Farm Animals And Cats
- Raman Venkataramanan Receives APhA's Tyler Prize For Stimulation Of Research
- New Medicare Requirement For 'Face-to-Face' Encounters Could Have Negative Consequences For Home Health Care And Hospice Patients